Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial (Q67223888)
Jump to navigation
Jump to search
scientific article published on 12 June 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial |
scientific article published on 12 June 2011 |
Statements
Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial (English)
Dariusz Dudek
Gregg W Stone
Bernard J Gersh
Jan Z Peruga
George Dangas
Giulio Guagliumi
Ran Kornowski
Helen Parise
HORIZONS-AMI Trial Investigators
Bruce R Brodie
Franz Hartmann
Stuart J Pocock
S Chiu Wong
1 reference